Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Ipilimumab/nivolumab

Hypothyroidism and addison's disease: case report

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Tahover E. An exceptional response to immunotherapy doublet in combined hepatocellular carcinoma-cholangiocarcinoma. Annals of Oncology 30 (Suppl. 7): vii15 abstr. 49P, Nov 2019. Available from: URL: http://doi.org/10.1093/annonc/mdz413.054 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ipilimumab/nivolumab. Reactions Weekly 1791, 150 (2020). https://doi.org/10.1007/s40278-020-74995-z

    Download citation